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Abstract: B a c k g r o u n d: Uterine leiomyoma is the most widespread benign tumor affecting women of 
childbearing age. There are still gaps in the understanding of its pathogenesis. Telocytes are unique cells 
found in more than 50 different locations inside the human body. The functional relationship between 
cells could clarify the pathogenesis of leiomyomata. Examination of membrane receptors on telocytes 
could explain their role in fibrosis, oxidative stress, and myometrial contractility. 
A i m: This research was conducted to assess the density of telocytes in terms of their putative role in 
leiomyoma formation by focusing on their correlation with the expression of estrogen and progesterone 
receptors. 
M e t h o d s: For gross evaluation of uterine tissue samples from leiomyoma, routine histology of adjacent 
and unaffected myometrium was performed. Immunohistochemical analysis of c-kit, tryptase, CD34, 
PDGFRα (telocyte-specific), and ER and PRs (estrogen and progesterone receptors) was performed to 
examine uterine telocytes and the expression of sex steroid receptors. 
R e s u l t s: The decline in telocyte density in leiomyoma foci was correlated with high progesterone 
expression and low estrogen receptor expression. The unchanged myometrium showed the opposite 
correlation and balance between both steroid hormone receptors. The difference in sex steroid receptor 
expression is correlated with the density of uterine telocytes, which emphasizes their conductor function. 
C o n c l u s i o n s: A reduction in telocyte density and the changes in examined marker expression demon-
strate the involvement of telocytes in local homeostasis. The expression of membrane receptors explicitly 
indicates their functional potential in the human myometrium, focusing attention on contractility and 
local homeostasis. 
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Introduction 
Uterine leiomyomas, also known as fibroids, represent a major public health problem 
and can be spontaneously diagnosed as a factor contributing to infertility among 
women of childbearing age. Leiomyoma is a benign, monoclonal diploid, and highly 
common gynecological tumor originating from uterine smooth muscle tissue [1–3]. 
The main pathological feature is the production of excessive quantities of extracellular 
matrix (ECM) and consequent fibrosis development [2]. The primacy of the trans-
formation of a single myocyte into a leiomyoma is not clear [4]. Genetic, chromoso-
mal, and epigenetic transformations as well as growth factors, cytokines, and steroid 
hormones may promote tumor growth [3, 4]. Controversy exists regarding the role of 
sex steroids in fibrosis development and the pathogenesis of uterine leiomyoma. 
Nevertheless, it is well known that a combination of estrogen and progesterone reg-
ulates most of the genes that encode growth factors [3]. Leiomyoma has a mechanical 
impact on myometrial contractility and induces a chronic local inflammatory reac-
tion, making implantation almost impossible. In some cases, patients with leiomyoma 
have abnormal myometrial peristalsis and low levels of cytokines essential for im-
plantation, which can also be considered contributing factors to infertility [5–7]. 
The majority of estrogen receptors are nuclear, whereas only up to 10% are located 
in the cell membrane [8–10]. Nuclear receptors are divided into the alpha (ERα) and 
beta (ERβ) subtypes [4], which are coexpressed in different kinds of tissue. However, 
the human myometrium is characterized by the prevalence of ERα receptor expression 
[11]. Membrane estrogen receptors have been revealed in cytoplasmic organelles 
(mostly in mitochondria and the endoplasmic reticulum), but their role is still un-
known [9]. There is no doubt that estrogen receptors are essential for the development 
and growth of leiomyoma, which express both kinds of estrogen receptors. Estrogen- 
related aberrations are common in such patients [12, 13] because of the impact on the 
expression of growth factors via several signaling pathways [3]. For instance, estrogens 
upregulate platelet-derived growth factor (PDGF) expression in leiomyoma cells and 
downregulate epidermal growth factor (EGF) expression. At the same time, they 
upregulate the expression of epidermal growth factor receptor (EGFR) in both myo-
metrium and leiomyoma cells [3, 14]. 
Progesterone receptors (PRs) are also divided into two groups, nuclear and mem-
brane, which have rapid nonclassical action and therefore attract the attention of 
scientists [15, 16]. Nuclear progesterone receptors are also divided into alpha (PR-A) 
and beta (PR-B) subtypes, each of which has a different role. The beta subtype 
activates progesterone-responsive genes, while the alpha type can repress the activity 
of progesterone receptor beta [17]. The ratio of the two isoforms is not stable and 
depends on the phase of the cycle (physiological changes) and probably also on 
diseases. Membrane progesterone receptors reflect the nongenomic action of steroids. 
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They are comprised of proteins, including progesterone membrane components 1 and 
2 and membrane progestin receptors (mPRs). The role of membrane receptors is often 
described outside of the female reproductive system. Thomas et al. demonstrated that 
these kinds of steroid receptors are expressed in the central nervous system, where 
they participate in a variety of nonclassical progesterone actions in neural tissues [16]. 
Nevertheless, progesterone and its receptors stimulate cell proliferation, the accu-
mulation of extracellular matrix, and cellular hypertrophy, which form the back-
ground of leiomyoma development [3]. According to the literature data, the expres-
sion of PR-A and PR-B is significantly higher in leiomyoma tissue than in normal 
myometrium. Progesterone upregulates the expression of epidermal growth factor 
(which has mitogenic activity) and transforming growth factor beta-3 (TGF-β3) with 
bimodal action. Ciavattini et al. hypothesized that progesterone could stimulate leio-
myoma cell growth by upregulating B-cell lymphoma 2 (Bcl-2) protein expression and 
downregulating tumor necrosis factor-alpha (TNF-α) expression [3, 18]. 
Telocytes (TCs) are a population of cells with a mesenchymal origin that have 
been identified in different organs in humans and animals [19, 20]. Many original 
articles and reviews have depicted their morphology, main features, criteria for iden-
tification, and possible roles [21–23]. We intend to emphasize the essence of their 
junctions and immunopositivity for sex steroid receptors in the context of the current 
study. These cells make homo- and heterocellular contacts with smooth muscle cells, 
blood vessels, nerves, immunocytes, stem cells, and other cell types. In addition, TCs 
are positive for both kinds of steroid hormone receptors [20, 24]. We also know that 
the myometrium in pregnant and nonpregnant women contains different numbers of 
telocytes, which reflects the correlation with the local hormonal balance. The next 
important point is that the density of TCs is decreased in tissue, which is affected by 
inflammation or fibrosis [20, 21]. All of the previously mentioned factors allow us to 
ask a question: “Does the immunopositivity for estrogen and progesterone receptors 
of uterine telocytes highlight their role in fibrosis development as conductor cells?” 
Our study aimed to reveal a correlation between uterine telocytes and the expres-
sion of estrogen and progesterone receptors in leiomyoma and unchanged myome-
trium in women. We suggest that the immunopositivity of TCs for sex steroid hor-
mone receptors could be an additional contributor to the pathophysiology of 
myometrial changes and local homeostasis. 
Material and Methods 
Subjects 
Ten patients with symptomatic intramuscular solid UL were scheduled for elective 
surgery (laparoscopic hysterectomy) and selected for the study group (10 women, 
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mean age 58.2 ± 10.3 years). The control group consisted of 9 patients (9 women, 
mean age 53.5 ± 11.4 years) who underwent elective surgery for other reasons and had 
no pre- or intraoperative signs of uterine fibroids. Hysterectomy was performed 
according to the standard procedure. Samples of tissue from the fibrotic foci and 
adjacent myometrium were obtained from the study group for further observation. 
Samples of unchanged myometrium were also obtained from the control group. All 
patients were surgically treated at the Institute of Gynecology, Jagiellonian University 
Medical College, in 2019–2020. 
Ethical approval 
The study was conducted in accordance with the moral, ethical, regulatory and 
scientific principles governing clinical research. All samples were retrieved 
with the approval of the Jagiellonian University Bioethical Committee using proce-
dures that conformed to the Declaration of Helsinki guidelines (protocol number — 
1072.6120.48.2018). 
Tissue processing 
Tissue samples from fresh hysterectomy specimens were collected and rinsed thor-
oughly with PBS (phosphate-buffered saline, 0.01 M, pH = 7.4), fixed in 4% phos-
phate-buffered paraformaldehyde, routinely processed and embedded in paraffin. 
Serial sections were cut and mounted on poly-L-lysine-coated glass slides. 
Routine histology 
The sections were deparaffinized, rehydrated and stained with either hematoxylin– 
eosin (H&E) to evaluate the gross tissue organization or Masson’s trichrome stain to 
detect collagen deposits. 
Immunofluorescence 
After deparaffinization and rehydration, the slides were incubated for 30 min in PBS 
with appropriate normal serum at room temperature, which was followed by over-
night incubation at 4°C in a solution of PBS with appropriate normal serum contain-
ing a mixture of primary antibodies. After 5 washes (10 min each) in PBS, the speci-
mens were then incubated for 1 h at room temperature with a mixture of secondary 
antibodies diluted in PBS. Indirect double immunofluorescence for identification of 
telocytes and sex steroid hormone receptors in sections was performed with polyclo-
nal rabbit anti-c-kit (1:100; code: A4502, Dako); monoclonal mouse anti-CD34 (1:100; 
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code: M7165, Dako); polyclonal goat anti-PDGFR alpha (1;100; code: AF-307-NA, 
R&D Systems); monoclonal mouse anti-tryptase (1:100; code: M7052, Dako); mono-
clonal mouse estrogen receptor (1:50; code: NCL-L-ER-6F11, Leica Biosystems); and 
monoclonal mouse progesterone receptor (1:100; code: Clone PgR636). Secondary 
antibodies included goat anti-mouse Alexa 488-conjugated antibody (1:400; code: 
115-545-146, Jackson ImmunoResearch), goat anti-rabbit Alexa 594-conjugated anti-
body (1:400; code: 111-585-144, Jackson ImmunoResearch), and donkey anti-goat 
Alexa 594-conjugated antibody (1:400; code: 705-585-003, Jackson ImmunoResearch). 
Negative controls were performed that omitted the primary antibodies. Finally, the 
slides were washed with two changes (10 min each) of PBS, cover-slipped with fluor-
escence mounting medium (Dako, Denmark) and covered with Menzel-Gläser glasses. 
The labeled specimens were analyzed immediately. 
Microscopic examination of telocytes, mast cells  
and collagen deposits 
Slides were examined using an MN800FL epifluorescence microscope (OptaTech, 
Warszawa, Poland) equipped with an Olympus DP74 digital camera. Digital images 
were collected at either 200× or 400× magnification. The qualitative analysis of 
cells was performed in 10 consecutive high-power fields (400×) using the compu-
ter-based image analysis system software Multiscan 18.03 (CSS, Warszawa, Poland). 
All samples were assessed by two independent specialists (each blinded to the other) 
without any knowledge of the clinical parameters or other prognostic factors to avoid 
bias. The use of mast cell tryptase staining enabled c-kit-positive mast cells to 
be distinguished from c-kit-positive TCs. TCs were considered cells that were 
c-kit-positive and tryptase-negative concurrently with the characteristic morphology 
in tissue samples. Additionally, cells that were double positive for CD34 and PDGFRα 
with the characteristic morphology and localization were also recognized as TCs. 
In all sections, the immunoreactive cells were evaluated with respect to the relative 
frequency (arbitrarily graded as very few = (+), few = +, moderate density = + +, 
high density = + + +). The same scale was used to describe estrogen and progesterone 
receptor expression in all tissue samples. The percentages of collagen deposits and 
muscle tissue were analyzed in specimens stained with Masson’s trichrome stain. The 
collagen and muscle fiber volume ratios were determined in ten different fields for 
each sample.   
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Results 
Histopathological description of tissue samples 
The cellular pattern of tissue samples affected and unaffected by leiomyoma myome-
trium was observed under a microscope. The histopathological changes in all uterine 
samples in the current study were determined by hematoxylin–eosin and Masson’s 
trichrome staining. Tissue samples from leiomyoma were characterized by islands 
in the extracellular matrix and divided groups of smooth muscle bundles without 
a regular orientation. The nuclei of spindle cells were mostly elongated (Fig. 1). In 
the foci of leiomyoma, muscle bundles form nodular structures. The tissue samples 
from the normal (unchanged) myometrium had smooth muscle bundles that main-
tained holistic structures. The adjacent myometrium had a less well organized struc-
ture in comparison with the unchanged tissue (from the “healthy” uterus). Light 
microscopy of uterine fibroids, adjacent myometrium, and normal myometrium using 
Masson’s trichrome staining of collagen revealed collagen to be abundant in the 
fibroid tissue, while the myometrium had sparse, well-aligned collagen bundles 
adjacent to smooth muscle cells. 
Expression of estrogen and progesterone receptors 
The normal (unchanged) myometrium has a high prevalence of estrogen receptor 
expression in comparison with progesterone expression. Numerous ER-positive nuclei 
were found in all areas. In the samples affected by leiomyoma, the balance between 
both steroid hormone receptors was changed. In the leiomyoma foci, progesterone 
receptor expression was increased and estrogen expression was decreased (Fig. 2). 
In addition, we found that the expression of estrogen receptors was lower in leiomyo-
ma than that in unchanged (“healthy”) myometrium, while the expression of proges-
terone receptors was increased. In adjacent myometrium in areas of unchanged myo-
metrium, which were close to a capsule of leiomyoma, expression of both types of 
receptors was decreased (vs that in normal and leiomyoma-affected tissue samples). 
However, the general pattern in both tissue samples resembled bundles of lines going 
in different directions (resembling fibers) (Table 1). 
Description of uterine telocytes 
Double-immunopositive cells for CD34 and PDGFRα were detected in all observed 
tissue samples of the human myometrium. Based on their morphology, immunopro-
file, and localization in the tissue, we believed that they represented uterine telocytes. 
Some of these cells were observed close to blood vessels. The unchanged myometrium 
86 Veronika Aleksandrovych, Anna Gil, Anna Wrona 
Fig. 1. Hematoxylin–eosin- and Masson’s trichrome-stained sections of human myometrium. The 
myometrium sections from the control group (A, B) compared with the sections of foci from leiomyoma 
(E, F) and adjacent myometrium from the same uterus (C, D). After Masson’s trichrome staining, 
collagen deposits were blue in color whereas muscle fibers were red in color. Fragments of disordered 
smooth muscle cells were separated by abundant extracellular matrix (ECM). Total magnification: 200×. 
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Fig. 2. Nuclear positivity for estrogen (green, Alexa Fluor 488) and progesterone (green, Alexa Fluor 488) 
receptors in myometrial samples in the unchanged myometrium (A, B), leiomyoma-affected myometrium 
(E, F) and adjacent myometrium (C, D). Total magnification: 400×. 
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has more double-positive cells in comparison with that in all samples from the uterus 
affected by leiomyoma. In the leiomyoma foci, fewer telocytes were revealed. The 
scant architectonics of the cellular patterns were mostly due to the abundance 
of collagen. In the same results, we analyzed c-kit-positive/tryptase-negative cells 
(Table 1). We also performed double immunolabeling of c-kit/estrogen receptors as 
well as c-kit/progesterone receptors in the myometrium to analyze the role of telo-
cytes, which were double-positive for both markers (Fig. 3, 4).  
Table 1.  Relative frequency of c-kit-positive/tryptase-negative, CD34–positive and PDGFRα- 
positive, estrogen receptor-positive and progesterone receptor-positive cells in different parts of 
the unchanged human uterus and uterus affected by leiomyoma. 0 = absent, (+) = very few, + = few, 









Uterus without  
leiomyoma 
Unchanged  
myometrium + + + + + + + + + + + 
Uterus with  
leiomyoma 
Adjacent  
myometrium + + + + + + + + 
Leiomyoma + + + + + + + 
Fig. 3. Myometrial tissue sample stained for progesterone receptors (green, Alexa Fluor 488) and c-kit 
(red, Alexa Fluor 594). Uterine telocytes, which were double-positive for both markers, had oval-shaped 
bodies and long cellular lengths and were located close to blood vessels (indicated by arrow). Total 
magnification: 400×. 
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Discussion 
The first description of the coexpression of estrogen and progesterone receptors and 
telocytes in the female reproductive system was made by Cretoiu SM, who first 
focused her attention on this question more than ten years ago [25–27]. Since that 
time, several scientific groups have observed telocytes in the reproductive systems 
(male and female) of humans and animals (camel, cow, rat, rabbit, mouse, vole and 
turtle) [28–34]. Even such conditions as pregnancy have not been omitted from that 
point of view [21]. 
To date, how sex steroids impact cell proliferation and why their receptors are 
distributed on other cells, including telocytes, remain unclear. According to published 
data, oviduct TCs express estrogen and progesterone-A receptors [3, 21, 27]. PR-A 
expression was recognized by most anti-PR antibodies, whereas PR-B expression was 
not detected [3]. Telocytes are not always positive for sex steroid hormone receptors. 
Their immunopositivity is correlated with localization and probably the hormonal 
regulation of muscular contractions. For instance, telocytes of the gallbladder are 
negative for estrogen and progesterone receptors, while they are always strongly 
Fig. 4. Myometrial tissue sample stained for estrogen receptors (green, Alexa Fluor 488) and c-kit (red, 
Alexa Fluor 594). Two double-positive cells with long lengths, which were located close to each other, 
were detected near the capsule of the leiomyoma (are depicted by arrows). Total magnification: 400×. 
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positive in the uterus and oviduct [20]. The role of telocytes in myometrial contrac-
tions was previously excellently described. Therefore, gallbladder muscular contrac-
tions were shown to not be regulated by sex steroids, which play their own role in 
carcinogenesis in the gallbladder [35, 36]. Gupta et al. showed the absence of ER 
expression in benign gallbladder lesions, while PR shows wide variation in expression. 
The opposite situation has been observed in malignant cases, which show high ex-
pression of ER and PR in benign metaplastic lesions [37]. 
Our results demonstrated a decline in the expression of nuclear ER receptors in 
leiomyoma, which proves the benign nature of the pathology. The increase in PR 
receptor expression might stimulate growth factors with mitogenic activity, such as 
transforming growth factor-β3, basic fibroblast growth factor, epidermal growth fac-
tor, and insulin-like growth factor-I, which are also common in leiomyoma [3]. 
Levin hypothesized that the role of membrane estrogen receptors might be con-
nected with the prevention of vascular injury or cardiac hypertrophy, sexual behavior, 
mechanisms of pain perception, osteoblast activity, neuroprogesterone synthesis, and 
fluid resorption in the colon [10]. Telocytes are widely present in the gastrointestinal 
tract and heart and are also involved in the activity of the autonomic nervous system 
[10, 37]. Their immunopositivity for estrogen receptors and localization might stress 
their possible role as conductors. 
Horn et al. compared the number of uterine telocytes in the myometrium of 
nonpregnant premenopausal women without uterine endometriosis with that in post-
menopausal women, the uterus with endometriosis and pregnant uteri. All four gy-
necological statuses are different in terms of the estrogen/progesterone balance. The 
highest level of progesterone in pregnant uteri was accompanied by the lowest number 
of telocytes. The highest number of telocytes (which was significant) was detected in 
the myometrium of nonpregnant premenopausal women, whose estrogen level is 
usually lower than that in patients with endometriosis based on the pathogenesis 
[38]. The number of telocytes is decreased in pregnancy [25]. We are not sure how 
the population of telocytes responds to pregnancy development. On the one hand, this 
rapid decline might be connected with the physiological enlargement of the uterus. 
However, this trend is reversible, and after delivery, the population of telocytes is 
restored in quantity. From another point of view, we observed a negative correlation 
between the number of telocytes and the level of progesterone or the expression of its 
receptors. This tendency is not typical for estrogen receptor expression. 
Ben-Nagi et al. reported a reduction in the level of glycodelin in patients with 
submucosal leiomyomas. The secretion of this protein, which promotes angiogenesis 
and suppresses natural killer (NK) cells, is regulated by progesterone [7]. Immuno-
positivity of TCs for progesterone receptors and their reduction in number in leio-
myoma might contribute to the local microenvironmental imbalance in glycodelin. 
TCs have a common dynamic in pathological conditions; fibrosis development is 
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accompanied by a decrease in TCs in psoriasis, leiomyomas, gallbladder disease, 
systemic sclerosis, and obstructive uropathy [39–43]. The common feature is that 
fibrosis and changes in sex steroid hormone/receptor expression are always correlated 
with the telocyte number. 
Our study confirmed that because of their immunopositivity for various receptors, 
uterine telocytes might be considered conductor cells. In terms of in gynecological 
pathology, leiomyoma often coexists with an infertility problem. We are sure that 
further detailed analysis of the correlation between the estrogen/progesterone balance 
in the myometrium and the density of telocytes will provide essential knowledge 
regarding the pathogenesis of leiomyomas. 
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